Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
An2 Therapeutics Ord Shs (ANTX)  
$2.42 0.05 (2.02%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 29,740,000
Market Cap: 71.97(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $2.28 - $21.53
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   AN2 Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel medicines for patients with rare infectious diseases. Co.'s initial product candidate, epetraborole, an antibiotic under development as a once-daily, oral treatment for patients with chronic non-tuberculous mycobacterial lung disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,787,778 1,894,632
Total Buy Value $0 $0 $16,053,772 $16,898,592
Total People Bought 0 0 2 2
Total Buy Transactions 0 0 2 9
Total Shares Sold 0 321,491 565,631 657,255
Total Sell Value $0 $6,268,666 $10,233,675 $11,689,612
Total People Sold 0 6 6 6
Total Sell Transactions 0 12 36 50
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 88
  Page 3 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Easom Eric Chief Executive Officer   •       •      –    2022-11-07 4 AS $15.90 $195,741 D/D (12,203) 4,907 -44%     
   Easom Eric Chief Executive Officer   •       •      –    2022-11-04 4 AS $15.80 $139,474 D/D (8,828) 17,110 -46%     
   Easom Eric Chief Executive Officer   •       •      –    2022-11-03 4 AS $15.67 $223,058 D/D (14,165) 25,938 -44%     
   Easom Eric Chief Executive Officer   •       •      –    2022-11-02 4 AS $15.07 $23,263 D/D (1,544) 4,907 -47%     
   Easom Eric Chief Executive Officer   •       •      –    2022-10-31 4 AS $15.39 $41,363 D/D (2,688) 6,451 -43%     
   Easom Eric Chief Executive Officer   •       •      –    2022-10-26 4 AS $15.10 $25,342 D/D (1,678) 4,907 -42%     
   Easom Eric Chief Executive Officer   •       •      –    2022-10-25 4 AS $15.69 $75,672 D/D (4,806) 6,585 -42%     
   Easom Eric Chief Executive Officer   •       •      –    2022-10-24 4 AS $16.17 $46,344 D/D (2,866) 11,391 -42%     
   Easom Eric Chief Executive Officer   •       •      –    2022-10-21 4 AS $16.29 $228,240 D/D (13,951) 4,907 -42%     
   Easom Eric Chief Executive Officer   •       •      –    2022-10-20 4 AS $16.68 $121,672 D/D (7,293) 18,858 -42%     
   Shah Rajeev M. 10% Owner   –       –       •   2022-08-04 4 B $7.99 $799 I/I 100 3,773,517 1.42 13%     
   Shah Rajeev M. 10% Owner   –       –       •   2022-08-03 4 B $7.48 $13,531 I/I 1,809 3,773,417 1.5 20%     
   Shah Rajeev M. 10% Owner   –       –       •   2022-07-27 4 B $7.91 $65,503 I/I 8,281 3,771,608 1.5 9%     
   Shah Rajeev M. 10% Owner   –       –       •   2022-07-26 4 B $7.71 $115,172 I/I 14,938 3,763,327 1.5 15%     
   Shah Rajeev M. 10% Owner   –       –       •   2022-06-21 4 B $7.99 $2,413 I/I 302 3,748,389 1.42 78%     
   Shah Rajeev M. 10% Owner   –       –       •   2022-06-14 4 B $7.97 $489,402 I/I 61,424 3,748,087 1.5 100%     
   Shah Rajeev M. 10% Owner   –       –       •   2022-06-13 4 B $7.90 $158,000 I/I 20,000 3,686,663 1.5 113%     
   Adjuvant Capital Management, Llc 10% Owner   –       –       •   2022-06-06 4 A $15.00 $397,665 I/I 26,511 413,156     -
   Adjuvant Capital Management, Llc 10% Owner   –       –       •   2022-06-06 4 D $15.00 $397,665 D/D (26,511) 2,184,224     -
   Aziz Kabeer Director   –       •       •   2022-06-06 4 A $15.00 $397,665 I/I 26,511 413,156     -
   Aziz Kabeer Director   –       •       •   2022-06-06 4 D $15.00 $397,665 I/I (26,511) 2,184,224     -
   Adjuvant Capital Management, Llc 10% Owner   –       –       •   2022-03-29 4/A B $15.00 $2,499,990 D/D 166,666 2,210,735 2.45     -
   Adjuvant Capital Management, Llc 10% Owner   –       –       •   2022-03-29 4/A A $0.00 $0 I/I 386,645 386,645     -
   Adjuvant Capital Management, Llc 10% Owner   –       –       •   2022-03-29 4/A A $0.00 $0 D/D 2,044,069 2,044,069     -
   Readnour Robin Shane Director   –       •      –    2022-03-29 4 B $15.00 $2,300,010 I/I 153,334 487,592 2.1 -30%     
  88 Records found
  1  2  3  4   
  Page 3 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us